Search Results
2022 KU Post San Antonio Review | Early-Stage Hormone + Breast Cancer: Optimizing Systemic Therapy
2022 KU Post San Antonio Review | Breast Cancer Risk Assessment and Reduction: What's New
2022 KU Post San Antonio Review | Metastatic HER2 Positive Breast Cancer: Novel Treatment Approaches
2022 KU Post San Antonio Review | (Neo)adjuvant Therapy for Triple Negative Breast Cancer
The San Antonio Breast Cancer Symposium (SABCS) 2022
Adjuvant Treatment for Early Stage Hormone Positive Breast Cancer: Role of Genomic Signatures
Breast Cancer Breakthroughs Episode One: Highlights from the San Antonio Breast Cancer Symposium
Dr. Shom Goel |San Antonio Breast Cancer Symposium 2022 | Year in Review
Guideline Updates for Extended Endocrine Therapy Decision-Making in HR+, Early-Stage Breast Cancer
2021 San Antonio Breast Cancer Symposium Update on MBC | 2021-2022 EMBRACE MBC Virtual Forum Series
Report Back from San Antonio Breast Cancer Symposium (SABCS 2022)
2022 West Oncology Conference | Breast Cancers | Early-Stage
